The effect of metoclopramide on gastric emptying in traumatic brain injury.

Abstract Objective Gastric paresis in traumatic brain injury (TBI) hinders the effectiveness of enteral support in this patient group. In this study we have investigated the effect of metoclopramide on gastric emptying in TBI patients. Method In this prospective, randomized, controlled, double-blind study, 19 TBI patients with Glasgow Coma Scale scores of 3–11 were included. In all patients, enteral nutrition was commenced with a nasogastric feeding tube within 48 hours of trauma. Patients were randomized into two groups. In the metoclopramide ( M ) group, 10 mg metoclopramide was delivered intravenously three times daily for 5 days. In the control ( C ) group, an equal volume of saline was administered. Besides demographics, gastric emptying according to a paracetamol absorption test at days 0 and 5, time to reach target nutritional requirements, gastric residues, intolerance to feeding, nutritional complications, and clinical outcomes were recorded for each patient. Results The gastric residue rates were 2.7 ± 7.4 mL and 8.1 ± 17.7 mL per 100 patient days for groups C and M respectively ( p  = 0.408). Similarly, feeding intolerance and complication rates did not significantly differ between groups C and M , (respectively p  = 0.543 and 0.930). Gastric emptying parameters also were similar between the study groups. Conclusion We were unable to document any advantage to using metoclopramide in TBI patients. Simple intragastric enteral feeding with close monitoring of the possible complications seems to be sufficient with acceptable morbidity rates.